Sarah James
Stock Analyst at Cantor Fitzgerald
(2.09)
# 2,793
Out of 4,846 analysts
279
Total ratings
33.02%
Success rate
-3.97%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Reiterates: Neutral | $290 | $230.76 | +25.67% | 21 | May 1, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $376.20 | +28.92% | 20 | Apr 23, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $314.61 | +16.02% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $23.72 | +22.26% | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $12.76 | +17.55% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $169.72 | +4.29% | 20 | Feb 13, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $405 | $381.64 | +6.12% | 19 | Jan 27, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $700 | $304.15 | +130.15% | 17 | Jan 17, 2025 | |
| CNC Centene | Reiterates: Overweight | $90 | $54.85 | +64.08% | 12 | Dec 11, 2024 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $21.67 | +139.96% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $17 | $21.76 | -21.88% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $187.02 | +17.10% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $406 | $297.67 | +36.39% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $23.40 | +83.76% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $3.78 | +323.28% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $63.52 | -2.39% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.49 | +235.57% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $6.91 | +44.82% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $94.42 | +6.97% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $134.40 | -1.04% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $21.37 | +96.54% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $3.88 | +29.03% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $5.42 | -7.75% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $15.45 | +35.92% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $58.41 | -33.23% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $69.60 | +177.32% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.84 | - | 2 | Mar 1, 2017 |
Humana
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $230.76
Upside: +25.67%
Elevance Health
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $376.20
Upside: +28.92%
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $314.61
Upside: +16.02%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $23.72
Upside: +22.26%
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $12.76
Upside: +17.55%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $169.72
Upside: +4.29%
HCA Healthcare
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $381.64
Upside: +6.12%
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $304.15
Upside: +130.15%
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $54.85
Upside: +64.08%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $21.67
Upside: +139.96%
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $21.76
Upside: -21.88%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $187.02
Upside: +17.10%
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $297.67
Upside: +36.39%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $23.40
Upside: +83.76%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $3.78
Upside: +323.28%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $63.52
Upside: -2.39%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.49
Upside: +235.57%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $6.91
Upside: +44.82%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $94.42
Upside: +6.97%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $134.40
Upside: -1.04%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $21.37
Upside: +96.54%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.88
Upside: +29.03%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $5.42
Upside: -7.75%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $15.45
Upside: +35.92%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $58.41
Upside: -33.23%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $69.60
Upside: +177.32%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.84
Upside: -